Genesis Conference 2016: Leadership Sessions – Digital Health

Brought to you by The Healthcare Group

CW presents a stream at the annual Genesis Conference.

Registration for this event is now closed.

About the event

Stream C 11.30-12.30
Industry Trends, Opportunities and Challenges

The growing presence of digital technology in how we detect, diagnose, manage and treat health disorders raises immense opportunities for patients, healthcare providers, payers and industry alike. That said, there are also significant challenges as we grapple with data protection, validation, regulatory and commercialisation dilemmas. This session will see speakers discuss these challenges and the trends emerging to address them and how an optimum outcome for all stakeholders may be achieved.

Stream C 14.00-15.00
Digital Health – Patient Engagement

Engaging patients at the earliest point is key to disease management whether that be slowing progression by monitoring symptom onset to managing complex co-morbidities. In the pharmaceutical sector engaging patients has been a difficult and unmeasured science, however that is now changing and digital technology is at the frontier of engaging patients to the point of self-management and in some cases disease prevention. This track session will look at the different digital technologies used and the successes they have had in engaging patients to enable the wider community to learn from these experiences to implement digital technology for patient engagement in the future.

Stream C 16.10-17.10
Investing in Digital Health

Digital Health covers a multitude of aspects and points of intervention in the healthcare pathway. Patient adherence, drug development, diagnosis, prevention and more can be enabled though the collection and appropriate use of valid data. For a clinician a mantra of ‘do no harm’ and a patient query of ‘do I trust someone with my data?’ highlights some of the people challenges that are not technical yet must be addressed. What is less clear for many is which business models are suitable in the digital health field. How can the data be valued or monetised, what are the risks and what are the exit routes for investors will all be discussed in this session to shed light on some of the strategies being developed right now.

SIG Champions

Peter Ferguson - Director of Connected Health, Capgemini UK plc

Michael Morgan-Curran - CEO, Asclepius MedTech Ltd

Michael has a successful track-record in ethical pharmaceuticals, medical technologies and digital therapeutics. Working with some of the world’s best-known pharmaceutical, life science, medical device, telecoms and research organisations across EMEA, US and Latam, he has built and led teams accountable for market intelligence, strategy, marketing and commercialisation, product design, regulation and market authorisation, pharmacovigilance, clinical trial development, clinical effectiveness and health economics.

As CEO of start-up Asclepius MedTech Ltd; he and his team are building a platform for use in pre- and post-operative surgical assessment to support clinicians and surgical teams ameliorate shared decision-making and stratify patient care.

Daniel Nickalls - Consultant, TTP plc

Daniel is a TTP project leader focussed on decentralized healthcare solutions including the detection and treatment of chronic conditions at home. These projects cover the entire development lifecycle, from early-stage ideation and opportunity validation, through proof-of-concept development, to regulated device development for large-scale manufacture. Daniel particularly enjoys combining engineering insights, rigorous human-centred design and thorough business case validation to realise effective solutions.

Laurence Weir - Freelance, Unaffiliated

Since graduating in Engineering from Cambridge University in 2006, Laurence has worked for Broadcom, Cambridge Mechatronics, Illumina and PA Consulting, and Plextek Services Ltd. Due to the range of sectors Laurence has worked in, from smartphone technology to DNA sequencing, he has an appreciation for the different skills and expertise required to deliver multi-disciplinary engineering projects, as well as the applicable regulatory environments that exist. His experience in business development is coupled with technology leadership on projects and practical engineering delivery.

Mick Withers - SVP Commercial Business Development, Plextek

Involved in Technology consulting around Cambridge for the last 34 years, Previous roles include Managing Director at Sagentia, as well as a couple of stints at TTP, and 5 years helping TeraView transition from a startup to a product company. Now I am charged with helping Plextek diversify its service offering into the Commercial (i.e. non-defence) space.

Event Location

Open in google maps

Location info

QEII Centre, Westminster, London, UK

Related events

  • Cambridge Wireless

    Risk, perception, management and mitigation in RF Safety

    Register now
  • Cambridge Wireless

    AI, Law and Ethics 101: a quick start guide to what you need to know

    Register now
  • Cambridge Wireless

    Member Networking 2024

    Register now

Subscribe to the CW newsletter

This site uses cookies.

We use cookies to help us to improve our site and they enable us to deliver the best possible service and customer experience. By clicking accept or continuing to use this site you are agreeing to our cookies policy. Learn more

Reserve your place

Join the CW network

CW is a leading and vibrant community with a rapidly expanding network of nearly 400 companies across the globe interested in the development and application of wireless and mobile technologies to solve business problems.

Sign in to your account

Please sign in to your CW account to reserve a place at this event and to qualify for any member discounts.

Start typing and press enter or the magnifying glass to search

Sign up to our newsletter
Stay in touch with CW

Choosing to join an existing organisation means that you'll need to be approved before your registration is complete. You'll be notified by email when your request has been accepted.

i
Your password must be at least 8 characters long and contain at least 1 uppercase character, 1 lowercase character and at least 1 number.

I would like to subscribe to

Select at least one option*